Status:
ACTIVE_NOT_RECRUITING
STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Catharina Ziekenhuis Eindhoven
Conditions:
Risk Reduction
Ovarian Cancer
Eligibility:
FEMALE
30+ years
Brief Summary
The aim of this study is to optimize implementation of the opportunistic salpingectomy throughout the Netherlands.
Detailed Description
The investigators aim to optimize implementation of opportunistic salpingectomy throughout the Netherlands. The investigators will evaluate the implementation by enrolling patients in a database to ev...
Eligibility Criteria
Inclusion
- Age from 30 years
- Undergoing gynaecological surgery in which currently both ovaries and fallopian tubes would be preserved
- Childbearing completed
- Able to understand the written or spoken Dutch language
- Consent for enrolment in database
- Consent for yearly checks of PALGA database and municipal administration
Exclusion
- Age under 30 years
- Undergoing surgery without residual ovarian tissue
- Child wish
- Unable to understand the written or spoken Dutch language
- Previous bilateral salpingectomy
- Previous bilateral salpingo-oophorectomy
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04470921
Start Date
January 1 2019
End Date
December 31 2025
Last Update
January 26 2024
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Jeroen Bosch Hospital
's-Hertogenbosch, Netherlands, 5223 GZ
2
OLVG
Amsterdam, Netherlands, 1091 AC
3
Academic Medical Centrum
Amsterdam, Netherlands, 1105AZ
4
Rijnstate Hospital
Arnhem, Netherlands, 6800 TA